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Site of Blood Vessel Damage and Relevance of CD18
in a Murine Model of Immune Complex-Mediated
Vasculitis
Anca Sindrilaru1,2, Stephan Seeliger1, Jan M. Ehrchen1,3, Thorsten Peters2, Johannes Roth1,
Karin Scharffetter-Kochanek2 and Cord H. Sunderko¨tter1,2,3
How neutrophils (polymorphonuclear neutrophils, PMNs) damage vessels in leukocytoclastic vasculitis (LcV)
mediated by immune complexes (ICs) is unclear. If degradative enzymes and oxygen radicals are released from
PMNs while adhering to the inner side of the vessel wall, they could be washed away by the blood stream or
neutralized by serum protease inhibitors. We investigated if in LcV PMNs could damage vessels from the tissue
side after transmigration. We used CD18-deficient (CD18/) mice because the absence of CD18 excludes
transmigration of PMNs. When eliciting the Arthus reaction in ears of CD18/ mice, deposition of ICs was not
sufficient to recruit PMNs or to induce IC-mediated LcV. Injection of PMNs intradermally in CD18/ mice
allowed us to investigate if bypassing diapedesis and placing PMNs exclusively on the abluminal side leads to
vascular destruction. We found that injected PMNs gathered around perivascular ICs, but did not cause vessel
damage. Only intravenous injection of wild-type PMNs could re-establish the Arthus reaction in CD18/ mice.
Thus, PMNs cause vessel damage during diapedesis from the luminal side, but not from the perivascular space.
We suggest that in order to shield the cytotoxic products from the blood stream, ICs induce particularly tight
interactions between them, PMNs and endothelial cells.
Journal of Investigative Dermatology (2007) 127, 447–454. doi:10.1038/sj.jid.5700563; published online 28 September 2006
INTRODUCTION
Leukocytoclastic vasculitis (LcV) is an inflammation of small
blood vessels (usually post-capillary venules) characterized
histologically by infiltration of neutrophils (polymorpho-
nuclear neutrophils, PMNs), karrhyorhexis of their nuclei
(leukocytoclasia), and damage of the vessel wall, coupled
with compromise of the lumen and extravasation of
erythrocytes (Sunderkotter et al., 2001). The term LcV is
frequently used synonymously with the term immune-
complex-vasculitis, as the precipitation of circulating im-
mune complexes (ICs) along the vascular wall is the most
frequent cause for the damage of small vessels. In humans,
this form of vessel injury is found for example in IgA-asso-
ciated Henoch-Scho¨nlein purpura, in IgG/IgM-associated
LcV (hypersensitivity vasculitis) and cryoglobulinemic vascu-
litis (Piette, 2004; Sunderkotter and Sindrilaru, 2006).
IC-mediated injury is also encountered in certain forms of
glomerulonephritis and causes tissue damage in autoimmune
diseases such as systemic lupus erythematosus or rheumatoid
arthritis (Lamprecht et al., 1999; Firestein, 2003).
In vitro large fixed ICs cause degranulation and oxidative
burst of PMNs with release of degradative enzymes and
oxygen radicals into the extracellular space. These cytotoxic
agents have been demonstrated to act synergistically in
damaging cultured endothelial cells (Lentsch and Ward,
2000) and in breaking down collagenous and noncollagen-
ous components of the vascular basement membrane
(Greenwald and Moy, 1980; Fligiel et al., 1984; Weiss and
Regiani, 1984).
These findings have led to the hypothesis that during LcV
in vivo deposited ICs prompt PMNs to adhere to the vessel
wall and to release cytotoxic agents close to endothelial cells.
However, it is not clear exactly where the damaging events
occur. If PMNs damage the wall of blood vessels while
adhering to endothelial cells and starting transmigration, the
cytotoxic substances released by PMNs upon binding to ICs
could be washed away by the blood stream (the shear stress
at the vessel wall amounts of 50 dyn per cm2; von Andrian
and Mackay, 2000), or their proteases could be neutralized
by the high concentrations of protease inhibitors in serum
(e.g. alpha 1 proteinase inhibitor (2–3.5 mg/ml), alpha 1 anti-
chymotrypsin (1.3mg/ml), or alpha 2 macroglobulin (2–4mg/ml)).
As interactions between adhesion molecules such as
CD18 and intracellular adhesion molecule-1 have been
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shown to be particularly relevant for IC-induced LcV or LPS-
induced vessel damage (Cochrane and Aikin, 1966; Salyer
et al., 1990; Argenbright and Barton, 1992; Lentsch and
Ward, 2000), it is possible that in IC-mediated LcV PMNs
adhere particularly tightly to the luminal vascular wall when
they release their cytotoxic substances. Yet, the contacts
between PMNs and EC during transmigration could be too
short-lived for the cytotoxic substances to attack endothelial
cells.
Another possibility is that damage to blood vessels could
occur mainly or exclusively from the abluminal side, after
PMNs have migrated through the vessel into the tissue. In this
case they would, upon binding to perivascular ICs, release
their cytotoxic contents close to endothelial cells, but remote
from the blood stream. This is conceivable because (i) in LcV
caused by circulating ICs or in the Arthus reaction (Art-r)
(Arthus, 1903), the deposition of ICs occurs on both the
luminal and abluminal sides of blood vessels (Braverman and
Yen, 1975; Clauss et al., 2001; Sunderkotter et al., 2001), (ii)
degenerating, non-apoptotic PMNs in the extravascular tissue
are regarded as the main source of proteases for vessel
damage (Varani et al., 1989), (iii) in a rat model of IC-
mediated lung injury, PMNs and macrophages responsible
for vessel damage are primarily found in the interstitium
(Johnson and Ward, 1974), and (iv) ultrastructural studies
show PMNs phagocytosing ICs in the extravascular space
during the Art-r (Kohda and Ueki, 1981; Crawford et al.,
1985).
Determining the exact site of vessel damage would be a
major step in deciphering the pathophysiology of IC-
mediated LcV and might be of help in finding specific
treatments. It is still unclear which particular events lead to
damage of the vessel wall in IC-mediated LcV, whereas it is
left unharmed in most other acute inflammatory disorders
(Braverman and Yen, 1975; Clauss et al., 2001; Sunderkotter
et al., 2001, 2004; Sunderkotter and Kolde, 2004).
The aim of this study was to investigate whether PMNs
could destroy the vessel wall from the abluminal rather than
from the luminal side in IC-mediated LcV.
To test this hypothesis, we employed the reverse passive
Arthus reaction in CD18-deficient (CD18/) mice. CD18 is
the common beta chain of the b2-integrins that appear to be
required for diapedesis of PMNs into the skin as CD18/
mice lack adherence and transmigration of PMNs in several
models of cutaneous inflammation (Walzog et al., 1994;
Mizgerd et al., 1997; Scharffetter-Kochanek et al., 1998;
Schonlau et al., 2000; Peters et al., 2005). The defective
recruitment can be successfully bypassed and the inflamma-
tory reaction restored, if PMNs or other leukocytes are
injected directly into the extravascular tissue (Chen et al.,
2002; Grabbe et al., 2002). This model allows the exclusive
placement of PMNs into the perivascular space and evalua-
tion of their vasotoxic potential while avoiding the actions of
adhering or transmigrating PMNs. It can also reveal if the
presence of ICs alone, that is, in absence of CD18, is
sufficient to recruit PMNs, as described for IC-mediated
glomerulonephritis or anti-glomerular basement membrane
nephritis (Tang et al., 1997; Coxon et al., 2001).
Because in humans in vitro signaling from b2-integrins
modulates receptor for the Fc fragment of immunoglobulin
(FcgR)-mediated adhesion of PMNs to ICs with subsequent
oxidative burst and degranulation (Lowell and Berton, 1999;
Ortiz-Stern and Rosales, 2003), we wanted to clarify before
our in vivo experiments if these steps would be impaired by
deletion of CD18 in murine PMNs (Graham et al., 1993;
Zhou and Brown, 1994; Lowell and Berton, 1999).
Our data show that (i) binding of murine PMNs to ICs as
well as IC-induced degranulation and oxidative burst by
PMNs are initially not affected by deficiency of CD18, but
only later after the first blow; (ii) the Art-r could not be
elicited in CD18/ mice and that deposition of ICs alone is
not sufficient for recruitment of leukocytes into the skin in
IC-mediated LcV; and (iii) in vivo PMNs do not damage
vessels from the protected interstitial side, but rather during
diapedesis from the blood stream.
RESULTS
CD18 is not mandatory for the initiation of degranulation of
PMNs in response to fixed ICs
For the Arthus reaction, degranulation and generation of
oxidative burst by PMNs binding to ICs are decisive events.
We analyzed these functions in murine CD18/ PMNs.
Elastase is one major enzyme implicated in endothelial
damage in IC-mediated vasculitis (Lentsch and Ward, 2000)
and a marker for degranulation. We measured elastase
release from PMNs after stimulation with fixed ICs and found
that in the absence of CD18, PMNs remain able to release
marked amounts of elastase, comparable with the release by
wild-type (WT) PMNs in the initial phase. At later time points,
degranulation of CD18/ PMNs was slightly – although
significantly – reduced when compared to WT PMNs (Figure
1a). This indicates that CD18/ PMNs release decreased
amounts of elastase and other proteases upon binding to fixed
ICs, but the released concentrations are still sufficiently
effective.
CD18 is not mandatory for the initiation of oxidative burst of
PMNs in response to fixed ICs
When PMNs were stimulated with fixed ICs, CD18/ PMNs
were capable of a respiratory burst comparable to that of WT
PMNs within the first 15 minutes. However, after 45 minutes
the release of oxygen radicals by CD18/ PMNs decreased
significantly compared to WT PMNs (Figure 1b). There was
no difference between PMNs from both genotypes when they
were activated with the FcgR-independent stimulant phorbol
ester.
Thus, the absence of CD18 does not abolish the initial
adhesion-dependent respiratory burst in IC-stimulated
CD18/ PMNs, while it results in up to 30% decrease in a
sustained reaction.
Sustained but not initial adherence to fixed ICs is impaired in
CD18/ PMNs
When incubating PMNs with ICs, we found that the number
of WT and CD18/ PMNs adhering to fixed ICs was similar
after 10 minutes (Figure 1c and d), whereas after 45 minutes
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the number of adhering CD18/ PMNs had declined by
50% (Figure 1c and d). This significant decrease compared to
WT PMNs correlated temporally with the observed reduction
in oxidative burst or in degranulation by CD18/ PMNs.
Thus, CD18 appears to be a factor in sustained adherence to
ICs with the release of oxygen radicals and degranulation, but
not for initiation of full degranulation and oxidative burst. Its
absence does not prevent the initial release of this full set of
agents with damaging potential for endothelial cells.
Formation of perivascular ICs in CD18/ mice does not lead to
recruitment of PMNs and subsequent vascular damage in the
Art-r
During the Art-r, WT mice showed a normal response with
edema and fine petechiae after 3 hours as well as progression
to numerous petechiae, hemorrhage, and marked swelling
after 6 hours. In contrast, CD18/ mice showed no
hemorrhage, significantly less swelling (Figure 2a–c), and
extravasation of FITC-BSA (Figure 2d). On histology, the ears
of CD18/ mice showed no infiltration of PMNs and no
signs of vascular destruction (Figure 2e). Thus, although
PMNs vividly bind to ICs, the deposition of ICs along the
vessel wall was not sufficient to guide recruitment of PMNs
into the tissue in vivo. This lack of recruitment resulted in the
inability of CD18/ mice to develop vasculitis.
In the Art-r the damage of the vessel wall does not occur from
the abluminal side
Next, we bypassed the impaired recruitment of PMNs by
injecting CD18/ PMNs directly into the skin of CD18/
mice, parallel to eliciting the Art-r. This enabled us to see
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Figure 1. In murine PMNs b2-integrins are not mandatory for initial
IC-elicited adhesion, degranulation, and oxidative burst. Peripheral
blood-derived PMNs from CD18/ and WT mice were stimulated with fixed
ICs. (a) Degranulation assessed as the increase in fluorescence intensity of DQ
elastin cleaved by the neutrophil elastase. Results are expressed in relative
fluorescent units as the ratio of fluorescence intensity between IC-stimulated
and unstimulated PMNs. (b) Oxidative burst expressed as the increase of
fluorescence intensity of oxidized carboxy H2DCFDA; results are also
expressed in relative fluorescent unit. Data representative for at least two
different experiments are given as mean7SD for triplicate samples of each
mouse (n¼ 4). Adhesion of PMNs on IC-coated (c) or BSA control-coated
slides (d) was measured by counting adherent PMNs in 10 high-powered
fields (40). Results are expressed as mean adherent PMNs/high-power field.
Each symbol indicates the median of a triplet analysis. Bars indicate median
of each cohort (n¼6). *Po0.05 according to Student’s t-test.
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Figure 2. In the Art-r vascular deposition of ICs does not lead to recruitment
of PMNs or to vessel damage in CD18/ mice. The Art-r was elicited by
injecting BSA intraperitoneally and anti-BSA-IgG subcutaneously in the left
ear. (a) Clinical picture showing petechiae and hemorrhage in WT mice
(upper panel) and the absence of these signs in CD18/ mice (lower panel).
(b) Semiquantitative score for hemorrhage indicating progressive, extensive
vascular damage in WT mice, and no vessel injury in CD18/ mice.
(c) Extravasation of FITC-BSA as a marker for permeability of damaged
vessels was almost absent in CD18/. (d) Ear swelling as a parameter
of edema and infiltration was assessed by measuring ear thickness. No ear
swelling was observed in CD18/. Data given as mean7SD for a
representative experiment, n¼6, **Po0.01, ***Po0.005 according to
Student’s t-test. (e) Histological sections reveal typical signs of LcV, with
edema, vessel damage, and extravasation of erythrocytes and inflammatory
cells (arrows and inset) in WT mice (left panel), whereas in CD18/ mice
PMNs were trapped within the vessels (arrows and inset) and failed to
transmigrate or to induce vascular damage. Bar¼200 mm, inset 30 mm.
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whether PMNs exclusively placed extravascularly would
damage blood vessels from the abluminal side in response to
perivascular ICs as there could not be any contribution from
transmigrating PMNs. However, after transfer of PMNs in the
Art-r we did not detect a vasculitic reaction, neither by
clinical signs (petechiae and hemorrhage) (Figure 3a) nor
by relevant extravasation of FITC-BSA (Figure 3b) or by
histological criteria. This was remarkable as injected PMNs
not only were morphologically intact, but also partially
concentrated around vessels with deposited immunoglobu-
lins (Figure 3c and d). This inability of injected PMNs to
damage vessels from the abluminal, perivascular side despite
presence of ICs was unrelated to absence of CD18, because
injection of WT PMNs likewise did not result in clinical
(Figure 3a and b) or histological signs (data not shown) of
LcV. There appeared to be no major defect in migration or
morphological integrity of injected PMNs, as several intact
PMNs had accumulated close to vessels with deposited IgG
(Figure 3d and e). In contrast, LcV could be completely
restored by injecting WT PMNs intravenously into CD18/
mice when eliciting the Art-r. This was determined by
evaluating hemorrhage (Figure 3c), ear swelling (Figure 3d),
and histology (Figure 3e).
Although ICs are deposited at both sides of the vessel wall
in the Art-r and in IC-mediated LcV in humans (Braverman
and Yen, 1975; Sunderkotter et al., 2001), PMNs do not
damage the vascular wall from the abluminal side after they
have completed transmigration or after they have been
placed there. Thus, the PMN-mediated destruction must
rather take place during their transmigration from the luminal
side.
DISCUSSION
The distinct mechanisms that lead to damage of blood vessels
in IC-mediated LcV, but not in other acute inflammatory
conditions, are not well understood. Better knowledge
of this process would help to develop more specific
treatments of LcV, rather than the relatively non-specific
anti-inflammatory and immunosuppressive approaches cur-
rently used (Sunderkotter et al., 2005). Whether the damaging
events occur at the abluminal, perivascular side of the vessel
or at the luminal side where cytotoxic agents released from
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Figure 3. In the Art-r the damage of the vessel wall does not occur from the abluminal site. Viable PMNs were injected intradermally shortly after eliciting
Art-r in CD18/ mice. (a) Semiquantitative score assessed macroscopically and (b) extravasated FITC-BSA show that neither CD18/ nor WT PMNs are
capable of damaging the vessels from the abluminal site. When WT PMNs were injected intravenously in CD18/ mice after eliciting the Art-r, the
semiquantitative score of (c) hemorrhage and the (d) ear swelling show full development of IC-mediated vasculitis. Data given as mean7SD, n¼5, ***Po0.005
according to Student’s t-test. (e) HE staining showing vascular damage produced by intravenous injected cells (arrow) with extravasation of leukocytes
and erythrocytes, whereas CD18/ neutrophils can be still seen within intact vessels as they do not transmigrate (open arrow). (f) Intact injected PMNs
are seen close to dilated vessels (closed arrows), but do not cause vessel damage (open arrow). Bar¼ 30 mm. (e) Immunofluorescence stainings showing in the
upper panel that ICs (green) are deposited around CD31-positive vessels (red) and in the lower panel GR-1-positive PMNs (red) colocalizing with ICs
(green) at the vessel wall (overlay, yellow). Bar¼ 100mm.
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PMNs could be washed away or neutralized had not been
investigated so far.
In our study, we demonstrate that PMNs do not cause
damage at the abluminal side; instead, the vessel destruction
occurs during PMNs transmigration from the blood stream.
We also show that in IC-mediated LcV, vascular deposi-
tion of ICs alone is not sufficient to recruit PMNs and to cause
LcV in absence of CD18, and that deficiency of CD18 does
not prevent the full initial degranulation or oxidative burst in
response to ICs, but instead the maximal and sustained
activation of these functions.
Adhesion to ICs, adhesion-induced activation and dama-
ging action of PMNs on vessels appear to be closely
connected processes, as (i) respiratory burst, granule secre-
tion, and other major functions of PMNs in vitro are usually
dependent on stimulation by both an inflammatory stimulus
and by immobilization or adherence (Nathan et al., 1989;
Lowell and Berton, 1999; Ortiz-Stern and Rosales, 2003),
(ii) sustained adhesion to ICs of PMNs with generation of an
oxidative burst requires co-stimulation or cross-talk of signals
from FcgR and integrins (Jones et al., 1998; Lowell and
Berton, 1999; Jongstra-Bilen et al., 2003), and (iii) in vivo firm
adhesion of PMNs to endothelial cells is required for vascular
damage in the Art-r (Norman et al., 2003; Stokol et al., 2004).
Our results suggest that the interactions between FcgR and
b2 integrins are not mandatory for the initial IC-elicited
degranulation and oxidative burst of murine PMNs in vitro,
but that their absence is associated with subsequent
attenuated generation of oxygen radicals and moderate
decrease in degranulation. This was coupled to a reduction
in sustained adherence to ICs in absence of CD18, confirm-
ing a two-phase kinetics with CD18-independent and CD18-
dependent processes as reported for human PMNs (Zhou and
Brown, 1994).
Our in vivo finding that in the cutaneous Art-r, the
presence of ICs is not sufficient to recruit PMNs in the
absence of CD18 is in contrast to IC-mediated glomerulo-
nephritis or anti-glomerular basement membrane nephritis
where PMNs were recruited also in Mac-1-deficient mice
(Tang et al., 1997; Coxon et al., 2001). This shows that CD18
is mandatory for recruitment of PMNs in the skin, indepen-
dent from the kind of inflammatory reaction. In several other
organs, it is not mandatory for leukocyte recruitment
(Mizgerd et al., 1997; Scharffetter-Kochanek et al., 1998;
Walzog et al., 1999; Schonlau et al., 2000).
Owing to this lack of adhesion and transmigration of
PMNs in dermal vessels of CD18/ mice, intradermal
injection of PMNs makes it possible to determine whether
PMNs can damage vessels from the abluminal side. Previous
studies had demonstrated that ICs are deposited at both sides
of the vessel wall in the Art-r and in LcV (Braverman and Yen,
1975) – or that they are even primarily formed in the
perivascular tissue in the Art-r (Cream et al., 1971; Norman
et al., 2003). They also showed that PMNs bind or
phagocytose these perivascularly located ICs in the Art-r
(Kohda and Ueki, 1981; Crawford et al., 1985). In our study,
we detected intact injected PMNs directly at the external
vessel wall in colocalization with perivascular deposits of
immunoglobulins, but we did not find any clinical or
histological signs of vessel damage. As we obtained the same
results after injection of WT PMNs, the decrease in sustained
release of cytotoxic agents by CD18/ PMNs observed in
vitro was not responsible for this lack of damage. We cannot
completely exclude that isolated WT and CD18/ PMNs
have changed their functional status ex vivo, but there was no
evidence for marked alterations in those functions relevant
for LcV: isolated PMNs were able to degranulate and to
generate an oxidative burst in vitro, injected PMNs around
vessels appeared intact on histological and ultrastructural
analysis, and intravenous injection of isolated WT PMNs in
CD18/ mice completely restored IC-mediated LcV. Other
studies also showed that isolation and subsequent injection of
PMNs conserves several relevant functions (Chen et al.,
2002; Grabbe et al., 2002).
According to these results, the question remains how and
why cytotoxic substances released in response to large ICs by
blood-borne PMNs exert enough potential to cause cellular
damage without being neutralized or washed away by the
blood stream. One explanation may reside in the strategies
employed by PMNs in vitro to exert their proteolytic activity
in a milieu that contains efficient proteinase inhibitors. These
include high affinity of the enzymes to the substrate or to the
cellular membrane of the attacked cell, as well as the release
of proteases in concentrations that are higher than those of
their inhibitors, or compartmentalization of proteinases to
protected areas after adhesion of PMNs. This shielding of
proteases seems to require a sustained and firm contact of
PMNs to surfaces in vitro and in vivo (Owen and Campbell,
1999). Accordingly, a firm adhesion between PMNs and
endothelial cells appeared to be important for vascular
damage in the Art-r in two other studies (Norman et al.,
2003; Stokol et al., 2004). It remains unclear, however, how
sustained and firm contact of PMNs to endothelial cells is
achieved during the dynamic process of diapedesis. We
have evidence that adhesion molecules other than CD18 are
also of special importance for IC-mediated LcV as we
have previously shown that neutralizing E-selectin in the
Art-r, or VCAM-1 and E-selectin during the Shwartzman
reaction, markedly reduces vessel damage in these models
(Sunderkotter et al., 2001). The exact function of adhesion
molecules here does not appear to be related to recruitment
of PMNs or to stimulation of degranulation or oxidative burst
(Sunderkotter et al., 2001; Sunderkotter, unpublished data).
In ultrastructural studies, we have observed signs for a
disturbed transmigration of PMNs in IC-mediated LcV,
encompassing a prolonged or more frequent arrest of PMNs
in the space between endothelial cells and basal membrane
when compared to non-vasculitic inflammation. We spec-
ulate that PMNs could deliver their damaging blow to
endothelial cells at this particular site, which to some extent
is shielded from the blood stream. In addition, products of
oxidative burst and degranulation can remain highly loca-
lized to membrane regions where FcgR binds to ligands
(Naucler et al., 2002). Therefore, we hypothesize that in
IC-mediated vasculitis interactions between ICs, FcgR, and
adhesion molecules cause disturbances in transmigration and
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in controlled activation of PMNs leading to accumulation of
cytotoxic agents at the basement membrane and their
concentration in small, defined subendothelial spaces. These
combined effects may then deliver the initial damaging blow
to endothelial cells.
MATERIALS AND METHODS
Mice
CD18/ (129xC57BL/6 (H-2b)) mice were generated as described
(Scharffetter-Kochanek et al., 1998) and used for all experiments at
8–12 weeks of age. As controls, CD18WT mice were obtained as
litters from heterozygote crosses. All experiments were performed in
compliance with the German Law for Welfare of Laboratory
Animals.
Reverse passive Arthus reaction in skin
The Art-r was elicited by injecting 2.5 mg BSA (Sigma, Taufkirchen,
Germany, Taufkirchen) in 200 ml phosphate-buffered saline (PBS)
intraperitoneally and immediately afterwards 10 mM/20 ml rabbit IgG
against BSA (Sigma) subcutaneously in the left ear.
Macroscopic criteria for evaluating the severity of inflammation
and vessel damage were: ear swelling, as a parameter for edema and
infiltrate and petechiae or hemorrhage as a parameter for the extent
of vascular destruction.
Ear thickness was measured with a spring-loaded Oditest caliper
(Kroeplin, Schu¨chtern, Germany) after 3 and 6 h. Contralateral ears
served as controls. The extent of hemorrhage was measured
semiquantitatively by evaluating the number and size of hemor-
rhages per ear as described previously (Sunderkotter et al., 2001).
In order to quantify vessel damage the amount of extravasated
fluorescence-labeled BSA (FITC-BSA) (Sigma, Germany) was mea-
sured as described previously (Clauss et al., 2001). Briefly, mice
were injected intraperitoneally with 2.5 mg FITC-BSA instead of
unmarked BSA for elicitation of the Art-r. Subsequently, skin
punches of 8 mm were harvested from the ears after 6 hours, cut
in slices of 1 mm and subjected to 2 ml trypsin (Biochrom, Berlin,
Germany) for 40 minutes. The extravasated fluorescent dye was
measured using a fluorescence photometer by 517 nm (FluorMax2
with DataMax for Windows; ISA, Jobin Yvon-Spex, Instruments S.A.,
Inc., Edison, NJ).
Histology
For histological analysis five mice of each strain were killed 6 hours
after eliciting the inflammatory reaction. Treated and control ears
were excised and cut longitudinally into two halves; one-half was
fixed in 4% paraformaldehyde, embedded in paraffin and stained
with hematoxylin and eosin according to conventional procedures;
the other half was immediately snap-frozen in liquid nitrogen.
Frozen sections were cut and fixed in cold acetone and stored at
801C.
Immunofluorescence staining
For immunofluorescent double staining (Frosch et al., 2005), we
used anti-CD31 IgG (PharMingen, Hamburg, Germany) as first
antibody and Cy3-labeled IgG (Caltag, Hamburg, Germany) as
second antibody, as well as Alexa Fluor488 anti-mouse Ly-6C and
Ly-6G (GR-1) and Alexa Fluor488-labelled goat-anti-rabbit IgG
(Caltag). Antibodies and isotype controls were diluted in 1%
BSA-containing PBS. Slides were visualized with a Zeiss Axiophot
microscope (Carl Zeiss Inc., Oberkochen, Germany).
Isolation of PMNs
Owing to the high number of PMNs needed for the assays,
experimental settings were established by using bone marrow-
derived PMNs, but the final data depict representative experiments
using PMNs isolated from peripheral blood. PMNs were separated
from bone marrow cells flushed from femurs by density gradient
centrifugation using Histopaque 1077 and 1119 (Sigma, Germany).
For PMNs from peripheral blood, EDTA-treated whole blood
obtained by axillary puncture was diluted with PBS and subjected
to Ficoll (Biochrom, Germany) density gradient centrifugation. After
washing procedures, viable (Trypan blue assay) PMNs were counted
and re-suspended in PBS or Hank’s balanced salt solution
(Biochrom, Germany) at the requested concentrations.
Transfer of PMNs
For the transfer experiments, 1 106 CD18/, respectively WT
PMNs, were injected intradermally in the left ear immediately after
eliciting the Art-r. In another set of experiments, 1 106 CD18þ /þ
PMNs were injected in 200ml PBS intravenously in CD18/ mice
30 minutes after eliciting Art-r.
Adhesion of PMNs to IC-coated surfaces
Large precipitating ICs were simulated by immobilizing IC on glass
coverslips (NUNC, Roskilde, Denmark). Briefly, wells were treated
with poly-D-lysine 0.1 mg/ml for 1 h and then fixed with 2.5%
glutaraldehyde for 20 minutes. After washing with PBS, selected
wells were coated with BSA 1 mg/ml for 30 minutes, followed by
2 hours incubation with 0.1 M glycine (all from Sigma, Germany) to
reduce unspecific binding. Finally, 20mg anti-BSA was coated for
1 hour to obtain fixed ICs. PMNs suspended at 1 106/ml Hank’s
balanced salt solution were added to the wells and incubated at 5%
CO2 and 371C. After 15 or 45 minutes, non-adherent PMNs were
washed and coverslips were fixed with 4% formaldehyde and then
stained for Giemsa. Adherent PMNs were counted for each time
point and experiment in 10 high ( 40)-powered fields and results
are expressed as mean adherent PMNs/high-power field.
Degranulation assay (elastase assay)
To assess degranulation, WT and CD18/ PMNs were incubated
with the fluorescence-quenched substrate DQ-elastin (Molecular
Probes, Karlsruhe, Germany) at a final concentration of 0.15 mM for
30 minutes at room temperature. After washing, 2 105 PMNs/
200ml were added to IC-coated wells or to non-coated wells as
references as described above. Elastase release as a parameter of
degranulation was assessed in a time kinetics by the intensity of the
digested fluorescent substrate measured at 515 nm with a Twinkle LB
970 Fluorometer (Berthold Technologies, Bad Wildbad, Germany).
Oxidative burst
For assessment of oxidative burst, ICs were immobilized on
MaxiSorp surface immunoplates as described. Soluble ICs were
prepared using an equal molar ratio of anti-BSA IgG and BSA.
CD18/ and WT PMNs were loaded with 5mM 5-(and-6)-carboxy-
20,70-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA)
(Molecular Probes, Germany) at a final concentration of 1mM for
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30 minutes at room temperature. Cells were then seeded at
1 105 cells/well in the IC-coated or uncoated wells for stimulation
with soluble ICs or 1mg/ml phorbol ester as positive control.
Fluorescence intensity was measured as described above.
Statistical analysis
Results were expressed as arithmetic means (n¼ 6–10)7SD and
analyzed by a two-tailed Student’s t-test. Values of Po0.05 were
considered to be significant.
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